850 results on '"Narita, I."'
Search Results
2. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
3. Cumulative incidence of femoral localized periosteal thickening (beaking) preceding atypical femoral fractures in patients with rheumatoid arthritis
4. AB0641 CLINICAL BACKGROUND FACTORS RELATED TO SILENT OSTEONECROSIS OF THE FEMORAL HEAD UPON INITIATION OF STEROID THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
5. Acquired Downregulation of Donor-Specific Antibody Production After ABO-Incompatible Kidney Transplantation
6. WCN23-0583 GROSS HEMATURIA AFTER COVID-19 mRNA VACCINATION: A PROSPECTIVE COHORT STUDY
7. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates
8. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates
9. POS-398 GENOME-WIDE ASSOCIATION STUDY FOR MULTIPLE KIDNEY-RELATED TRAITS IN JAPANESE POPULATION
10. POS-887 GROSS HEMATURIA AFTER SARS-CoV-2 VACCINATION: QUESTIONNAIRE SURVEY IN JAPAN
11. Blood pressure, hypertension and the risk of aortic dissection incidence and mortality: results from the Japan-specific health checkups study, the UK biobank study and a metaanalysis of cohort studies
12. Dust Explosion Characteristics of Aluminum, Titanium, Zinc, and Iron-Based Alloy Powders Used in Cold Spray Processing
13. Synthesis, characterization of a CoSe 2 catalyst for the oxygen reduction reaction
14. Characterization of anti-P monoclonal antibodies directed against the ribosomal protein–RNA complex antigen and produced using Murphy Roths large autoimmune-prone mice
15. Cobalt nanocrystallites encapsulated in boron nitride shells
16. The Effect of Kidney Transplantation On Bone Metabolic Markers and Bone Mineral Density.: Abstract# C1778
17. Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy
18. EFFICACY OF TRIPLET ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: PALONOSETRON, APREPITANT, AND DEXAMETHASONE
19. Cumulative incidence of femoral localized periosteal thickening (beaking) preceding atypical femoral fractures in patients with rheumatoid arthritis
20. THU0155 SERUM MYOSTATIN IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ITS CORRELATION WITH BODY COMPOSITIONS.
21. SAT0110 SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS ON THE TREATMENT WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
22. SAT0147 EFFICACY AND SAFETY OF IGURATIMOD AS FIRST-LINE DISEASE-MODIFYING ANTIRHEUMATIC DRUG THERAPY FOR PATIENTS WITH RHEUMATOID ARTHRITIS
23. AB0297 THE LONG-TERM OBSERVATION OF PATIENTS WITH RHEUMATOID ARTHRITIS WHO ACHIEVED A BIO-FREE CONDITION WITH ADALIMUMAB.
24. FRI0440 RISK FACTORS FOR CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH AUTOIMMUNE DISEASES
25. AB0539 URINARY INFLAMMATORY CELL ANALYSIS REFLECTS THE RENAL HISTOPATHOLOGY IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
26. The Effect of Lifestyle on the Mortality Associated with Respiratory Diseases in the General Population
27. SAT-412 TEN-YEAR TRENDS IN DIAGNOSIS OF KIDNEY DISEASES IN JAPAN -THE JAPAN KIDENY DISEASE REGISTRY/JAPAN RENAL BIOPSY REGISTRY (J-KDR/J-RBR)
28. The genetic susceptibility to IgA nephropathy: A novel functional candidate gene for incomplete O-glycosylation of IgA1
29. Expression of allograft inflammatory factor-1 in kidneys: A novel molecular component of podocyte
30. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients
31. Transforming growth factor-β1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy
32. Renoprotective efficacy of renin–angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism
33. Peroxisome proliferator-activated receptor γ C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy
34. Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy
35. The clinical significance of effector T cells in the urine of patients with IgA nephropathy
36. Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with lgA nephropathy. (Letter to JMG)
37. Genetic polymorphism in angiotensinogen promotor region affects progression of IgA nephropathy
38. SUN-031 INCIDENCE OF GLOMERULAR DISEASES DURING THE PAST TEN YEARS IN JAPAN -THE JAPAN KIDENY DISEASE REGISTRY/JAPAN RENAL BIOPSY REGISTRY (J-KDR/J-RBR)
39. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
40. OP0048 The utility of serum angiopoietin-1 and angiopoietin-2 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
41. FRI0056 Clinical features at the onset of lymphoproliferative disorder in patients with rheumatoid arthritis
42. SAT0396 The risk factors of serious infection in patients with rheumatoid arthritis
43. THU0385 Urinary inflammatory cells reflect histopathological kidney injury in patients with lupus nephritis
44. SAT0130 Improvement of nutritional conditions in patients with rheumatoid arthritis starting first disease modifying anti-rheumatic drugs
45. CLINICAL BACKGROUND FACTORS RELATED TO SILENT OSTEONECROSIS OF THE FEMORAL HEAD UPON INITIATION OF STEROID THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
46. Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome
47. SAT0214 An analysis of increasing spacing time for the intravenous administration of tocilizumab in patients with rheumatoid arthritis
48. THU0290 Clinical background factors related to silent osteonecrosis of the femoral head upon initiation of steroid therapy in patients with systemic lupus erythematosus
49. Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy
50. AB0374 Analysis of Spacing of The Intravenous Administration of Tocilizumab in Patients with Rheumatoid Arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.